Medicare

Whistleblower Law Collaborative Attends 24th Annual TAF Coalition Conference

BOSTON, Oct. 10, 2024 /PRNewswire/ -- Whistleblower Law Collaborative had a strong presence at The Anti-Fraud (TAF) Coalition 24th Annual…

1 month ago

Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release

Quantify Medical Sees Initial Success with Venowave VW5 Sales and Medicare/Medicaid Reimbursement TestTherma Bright Closes First Tranche of Non-Brokered Concurrent…

1 month ago

Capital Rx’s Ryan Kelly and Josh Golden Named to the Class of 2024 BenefitsPRO Luminaries Awards

NEW YORK, Oct. 9, 2024 /PRNewswire/ -- Capital Rx, the full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA) advancing…

1 month ago

Parcel Health(R) Offers Safer, Sustainable Paper Pill Bottles for Affordable Obesity Treatment

Parcel Health aims to continue to provide sustainable paper pill bottles to divert plastic from the waste stream and help…

1 month ago

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the…

2 months ago

DeepScribe launches DeepScribe Assist, real-time ambient intelligence for healthcare organizations

The breakthrough AI technology provides feedback to clinicians at the point of care, helping scale high-quality care and program compliance…

2 months ago

Quest Analytics® Achieves HITRUST r2 Certification for its Quest Enterprise Services® (QES®) Platform, Demonstrating the Highest Level of Information Protection Assurance

HITRUST Risk-based, 2-year Certification validates Quest Analytics is committed to strong cybersecurity and protecting sensitive data. OVERLAND PARK, Kan. , Oct.…

2 months ago

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

DENVER , Oct. 08, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing…

2 months ago

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to…

2 months ago